AI assistant
Sands China Ltd. — M&A Activity 2024
Dec 23, 2024
50273_rns_2024-12-23_76ef5c58-5c2e-4fe4-b9c9-48e8ad99b6c5.pdf
M&A Activity
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

宋基長壽科學
ZHONG JI LONGEVITY SCIENCE
Zhong Ji Longevity Science Group Limited
中基長壽科學集團有限公司
(Incorporated in Bermuda with limited liability)
(Stock Code: 767)
VOLUNTARY ANNOUNCEMENT
MEMORANDUM OF UNDERSTANDING
This announcement is made by Zhong Ji Longevity Science Group Limited (the "Company", together with its subsidiaries, the "Group") on a voluntary basis.
THE MEMORANDUM
The board (the "Board") of directors (the "Directors") of the Company is pleased to announce that, on 23 December 2024, Blooming Faith Development Limited ("Blooming Faith Development"), a wholly-owned subsidiary of the Company, and Happy Family (Beijing) International Travel Agency Co., Ltd.* (幸福萬家(北京)國際旅行社有限公司) ("Happy Family") entered into a memorandum of understanding (the "Memorandum"), pursuant to which Blooming Faith Development and Happy Family intend to jointly invest in establishing a joint venture in the People's Republic of China (the "PRC") (the "Possible Establishment of a Joint Venture").
The contemplated Possible Establishment of a Joint Venture will include both parties jointly investing in the establishment of a joint venture in the PRC to provide users with big health industry services such as longevity biological products, longevity medical testing, healthcare consumption, wellness and cultural tourism, etc., while providing a big health industry that consists of health industries combining accurate data empowerment, new media empowerment and consumer empowerment. Blooming Faith Development can provide products, services and management system support, while Happy Family can provide customer resources, wellness and cultural tourism resources,
and marketing and sales channels from the PRC. Both parties will continue to discuss the Possible Establishment of a Joint Venture and strive to sign a formal joint venture agreement as soon as possible. The Memorandum is not legally binding.
INFORMATION ON HAPPY FAMILY
Happy Family is a company established in 2022 in the PRC with limited liability. It is principally engaged in big health, wellness and cultural tourism, hotel management etc., and is a model enterprise that deeply integrates those fields. Committed to bringing convenience and happiness to thousands of households, Happy Family has strong resource integration and market development capabilities in the big health field.
To the best of the Director's knowledge, information and belief having made all reasonable enquiries, as at the date of this announcement, Happy Family and its ultimate beneficial owners are independent of and not connected with the Company and its connected persons (as defined in the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules")).
REASONS AND BENEFITS OF THE POSSIBLE ESTABLISHMENT OF A JOINT VENTURE
The Company is a company incorporated in Bermuda with limited liability and is an investment holding company. Through its subsidiaries, it is principally engaged in longevity science business, money lending, financial and investment advisory, as well as securities, property and investments. Blooming Faith Development is a company established in Hong Kong with limited liability. It is principally engaged in the research and development, transformation and application of longevity science. It operates through four major segments: longevity science research, longevity medical testing, longevity biological products, and longevity management. Blooming Faith Development has strong healthcare resources and self-developed quality products, including its own longevity biological products, longevity medical testing programs and other core products, and is committed to helping human beings live a long and healthy life.
The Board believes that the health and longevity science market has great prospects as it has been observed that affluent customers around the world are more willing to accept and spend money on longevity science applications to enhance their overall health and immune status and promote their physical rejuvenation.
The Possible Establishment of a Joint Venture is in line with the Group's longevity science business development strategy and plan and will be beneficial to the Group's future business development. The Board believes that the Possible Establishment of a Joint Venture will further improve the Group's layout in the field of longevity science diagnosis and medical services, and open up new sources of longevity science revenue for the Company, with a view to bringing more stable and sustained growth in revenue to the Group in the long run.
- 2 -
The Possible Establishment of a Joint Venture contemplated under the Memorandum is not legally binding. If the entering into of a legally binding agreement and the Possible Establishment of a Joint Venture are materialised, the Company will make a separate announcement in compliance with the Listing Rules, where applicable.
As the Possible Establishment of a Joint Venture may or may not proceed, the Company's shareholders and potential investors are advised to exercise caution when dealing in the Company's securities.
By order of the Board
Zhong Ji Longevity Science Group Limited
Yan Li
Chairman
Hong Kong, 23 December 2024
As at the date of this announcement, the Directors are:
Executive Directors
Mr. Yan Li (Chairman)
Mr. Yan Yifan (Chief Executive Officer)
Mr. Li Xiaoshuang
Ms. Cao Xie Qiong
Independent non-executive Directors
Mr. Lee See Barry
Mr. Huang Jiang
Prof. Huang Cibo
Non-executive Directors
Dr. He Yiwu
Mr. Lyu Changsheng
In the case of any inconsistency, the English text of this announcement shall prevail over the Chinese text.
- The English translation of the name in Chinese which is marked with “*” is for identification purpose only.